Day–night pattern of energy expenditure and body temperature in cachectic tumour-bearing rats by Oudart, H et al.
Tumour-bearing is frequently associated with a deterioration of the
body condition of the host, resulting in cancer cachexia. This
syndrome is characterized by a loss of body lipid and proteins
(Giacosa et al, 1996) and an increase in body water content
(Rechcigl et al, 1961). Anorexia is a common feature of cancer
cachexia, whereas the level of energy expenditure of the host has
been shown to be either increased, decreased or unchanged
(Keller, 1993). This effect on energy expenditure may be in rela-
tion to the type of tumour (Fredrix et al, 1991).
In healthy humans and animals, the level of energy expenditure
is directly related to the fat-free dry mass (Cunningham, 1991),
i.e. the metabolic active tissues which determine the level of the
resting energy expenditure. The other components of the total
energy expenditure are thermogenesis, activity energy expenditure
and diet-induced thermogenesis. During cancer cachexia, an
increase in the level of energy expenditure can be observed despite
a loss of fat-free dry mass of the host. In this way, in cancerous
patients, the resting and the non-resting energy expenditure could
contribute to elevation of the energy expenditure (Warnold et al,
1978; Lindmark et al, 1984). In a rat model of cancer cachexia
using the Morris hepatoma, the resting energy expenditure is
increased, whereas the total energy expenditure is unchanged, due
to a decrease in activity thermogenesis (Luketich et al, 1990).
Several studies have indicated an association between cancer
cachexia and fever (McCarthy and Daun, 1993; Tessitore et al,
1993). This increase in body temperature could be, at least in part,
responsible for an increase in energy expenditure. However, some
models of experimental cancer cachexia lead to a decrease of body
temperature (Smith et al, 1993) or to a fever in the first stage of
tumour development followed by a decrease under the normal
value in the later stage (Tessitore et al, 1993).
Thus, we investigated here the energy expenditure and the body
temperature in a well-characterized model of cancer cachexia. We
used the Yoshida sarcoma which induces an anorexia, a wasting of
muscle protein (Temparis et al, 1994), a loss of body lipid and protein,
and a negative nitrogen balance in the rat (Oudart et al, 1993). The
energy expenditure was measured by indirect calorimetry during the
last 24 h of tumour development and the results were standardized in
relation to the modifications of body composition. The body temper-
ature was measured throughout the tumour development.
MATERIALS AND METHODS
Animals, tumour and tumour transplantation
Male Wistar rats were purchased from IFFA-CREDO (Lyon,
France). They were kept in individual cages and provided ad
libitum with water and a standard diet (A03, UAR, France). Room
temperature was 26 ± 1° C. Light was on from 08:00 h to 20:00 h.
After 1 week, the tumour was implanted (TB group). Tumour was
implanted intramuscularly (i.m.) in the left rear leg with a small
piece of Yoshida sarcoma (1 mm3). Control rats were sham-
operated and received a heat-killed (60° C, 30 min) piece of
tumour. One group of control rats was pair-fed to the ad libitum
food intake of their respective tumour-bearing (PF group). Pair-
feeding was achieved by giving each pair-fed control the previous
day intake of its respective tumour-bearing rat. Ten days after
tumour implantation, which is a duration of tumour development
that avoids ulceration (Oudart et al, 1993), tumour-bearing and ad
libitum-fed control rats (AL group) were killed by cervical dislo-
cation between 9:00 and 10:00 h. Corresponding pair-fed controls
were killed 1 day later, according to the pair-feeding pattern. The
tumour, the retroperitoneal and epididymal white fat pads, the
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extensor digitorum longus muscles were rapidly excised and
weighed. The carcasses (body minus tumour) were frozen in liquid
nitrogen and stored at –20° C until composition analysis.
All experiments were done in compliance with European Union
regulations on care of experimental animals, and submitted to
control by French authorities.
First experiment: measurement of energy expenditure
In 18 rats (six in each group) oxygen consumption was measured
with an open-circuit indirect calorimetry (Klogor, France), as
previously described (Cimmino et al, 1996). Briefly, oxygen
concentration of the outgoing air was successively measured in
five different cages. The system was rinsed during 90 s between
each cage measurement. The final value for oxygen concentration
of the outgoing air was the mean of 10 measures obtained during
40 s. Each cage was sampled every 11 min, one cage was left
vacant and was used as reference for measuring ambient oxygen
concentration. Oxygen concentration was measured continuously
over 23.5 h per day, a 30-min period being required for calibration
of the oxygen analyser. One hundred and twenty-seven measures
were collected per day for each rat. The average of the five lowest
values was considered as corresponding to resting energy expendi-
ture. Energy expenditure was obtained by using an energy equiva-
lent of 20.27 J ml–1 O2.
Oxygen consumption was measured during the days 9 and 10 of
post-implantation (the two last days before the slaughtering of the
animals). Day 9 was considered as acclimatization and only day 10
was considered for the determination of energy expenditure.
Second experiment: measurement of body temperature
Battery-operated biotelemetry transmitters (Aktiv 500 Telemetry
System, GFT, Kiel, Germany) were implanted intraperitoneally
in 24 rats. Body temperature was recorded every 9 min with 
an automatic data collection system. One week later, tumour 
was implanted in eight rats (TB group), heat-killed tumour was
implanted in eight other rats (AL group). The following day,
heat-killed tumour was implanted in the last eight rats (PF
group).
The data of body temperature were analysed using the equation:
y = [A + B·cos(2π ·(t–C)/24)]
where A was the mean daily body temperature (° C), B the
amplitude of body temperature peak (° C), C the time of acrophase
(h), and t the standard time (h). This cosinor analysis was
performed on consecutive 4-day periods; each period of analysis
began 2 days before the end of the previous period of analysis.
Body composition analysis
For body composition analysis, the carcasses (bodies minus
tumour) were ground under liquid nitrogen, lyophilized, and
ground again to a fine powder. Total lipid was determined gravi-
metrically by a method adapted from Folch et al (1957). Lean
body masses (LBM) were determined by subtracting fat masses
from body masses. Fat-free dry masses (FFDM) were determined
by subtracting water masses from lean body masses. LBM and
FFDM included the tumour mass in the TB group.
Statistical analysis
Results are expressed as the means ± s.e.m. Statistical compar-
isons were performed with one-way ANOVA, followed by Tukey
test for multiple comparison or with Kruskall–Wallis test when
appropriate. Statistical significance was set at P < 0.05.
The data of food intake, body mass, body composition and
organ masses were found to be similar in the two experiments. The
results were therefore pooled and are presented as a single table.
RESULTS
Food intake, body and organ masses
Food intake (Figure 1) and body mass (Table 1) were similar in
the three groups of rats at the beginning of the experiment. In
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Table 1 Body mass, body composition, and organ masses in the tumour-
bearing rats (TB), pair-fed control rats (PF), and adlibitum-fed control rats
(AL)
TB PF AL
Initial body mass, g 200.5 ± 8.2 201.8 ± 3.5 202.3 ± 3.5
Tumour mass, g 14.5 ± 1.3 – –
Final carcass mass, g 230.6 ± 3.5a 225.6 ± 4.8a 263.8 ± 1.5
Carcass mass gain, g 30.6 ± 3.2a 23.5 ± 3.0a 62.1 ± 4.1
LBM, g 231.1 ± 4.6a,b 211.3 ± 5.6a 247.3 ± 2.8
FFDM, g 59.2 ± 4.4a 57.6 ± 3.6a 68.4 ± 1.9
EPI, g 1.53 ± 0.09 1.58 ± 0.13 1.76 ± 0.11
RP, g 0.98 ± 0.10a 1.16 ± 0.14 1.47 ± 0.13
Soleus, mg 142.2 ± 10.9a,b 156.5 ± 13.5 156.2 ± 15.7
EDL, mg 106.6 ± 3.1a,b 114.3 ± 3.7 118.5 ± 3.0
Liver, g 11.7 ± 0.4b 9.7 ± 0.3a 12.2 ± 0.4
BAT, mg 197.8 ± 10.1a,b 247.2 ± 16.0 299.7 ± 20.4
LBM: lean body mass including tumour mass; FFDM: fat-free dry mass; EPI:
epididymal white fat pads; RP: retroperitoneal white fat pads; EDL: extensor
digitorum longus; BAT: brown adipose tissue. aP < 0.05 vs AL; bP < 0.05 vs
PF. n = 14 per group. Means ± s.e.m.
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Figure 1 Food intake of tumour-bearing rats (   ), pair-fed control rats (   ),
and ad libitum-fed control rats (∆ ) during the tumour development. Day 0: day
of the implantation of the tumour. *P < 0.05 vs ad libitum-fed control rats;
n = 14 per group. Means ± s.e.m.tumour-bearing rats (TB), food intake decreased 5 days after
implantation of the tumour. Their food intake was compared to the
food intake 1 day before the tumour implantation, i.e. baseline
value, and to the ad libitum fed control rats (AL). After 10 days of
tumour growth, the food intake of the TB group was about 77% of
the baseline value and of the food intake of the AL group (Figure
1). During the period of tumour growth, i.e. 10 days, the pair-
feeding ensured an equivalent energy intake between the TB group
and the pair-fed group (PF) (Figure 1).
The final carcass mass (body mass minus tumour) and the
carcass mass gain did not differ between the TB group and the PF
group and were decreased in these two groups compared to the
values of the AL group (Table 1). The LBM including the tumour
mass was higher in the TB rats than in the PF ones. However, this
difference vanished when the tumour mass was not included
(216.6 ± 3.9 g in TB rats vs 211.3 ± 5.6 g in PF rats). The FFDM,
similar in the TB and PF groups, was lower than in the AL group
(Table 1).
The mass of epididymal white fat pads was similar in the three
groups. The mass of retroperitoneal white fat pad was lower in the
TB and PF groups than in the AL group but only the difference
between TB and AL groups reached the statistical significance
(Table 1). The masses of muscles (EDL and soleus) and BAT were
decreased in the TB group compared to the two control groups.
The mass of liver was lower in the PF group than in the TB and AL
groups.
Energy expenditure
Expressed in Watts (W) (irrespective of body mass), the total
energy expenditure in the PF group was 19% lower than in the AL
group and 11% lower than in the TB group. The total energy
expenditure did not differ between the TB and AL groups
(Table 2). Whatever the period (diurnal, nocturnal), the energy
expenditure in the PF group was lower than in the AL group.
Likewise, the resting energy expenditure was 16% lower in the PF
group than in the AL group. The diurnal and the nocturnal resting
energy expenditure were respectively 13% and 11% lower in the
TB group than in the AL group. The diurnal, nocturnal resting and
resting energy expenditure were respectively 12%, 20%, and 16%
higher in the TB group than in the PF group (Table 2).
Expressed per unit of LBM, the total energy expenditure did not
differ between the three groups. Excepted for the nocturnal resting
energy expenditure, there was no difference between the PF group
and the AL group. The diurnal and resting energy expenditures
were 7% higher in the TB group than in the AL group. Likewise,
the nocturnal resting and the total resting energy expenditure were,
respectively, 12% and 9% higher in the TB group than in the PF
group (Table 2).
Expressed per unit of FFDM, the results were similar to the
results expressed per unit of LBM, excepted for the total and the
diurnal energy expenditures. In the TB group, the total and the
diurnal energy expenditures were respectively 12% and 16%
higher than in the PF one (Table 2).
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Table 2 Energy expenditure in the tumour-bearing rats (TB), pair-fed
control rats (PF), and ad libitum-fed control rats (AL)
TB PF AL
Total energy expenditure
W 1.56 ± 0.07c 1.38 ± 0.06a 1.68 ± 0.04
W/kg LBM 6.74 ± 0.19 6.52 ± 0.16 6.80 ± 0.15
W/kg FFDM 26.8 ± 0.8c 24.0 ± 0.9 24.7 ± 0.7
Nocturnal energy expenditure
W 1.70 ± 0.09b 1.52 ± 0.09b 1.96 ± 0.06
W/kg LBM 7.34 ± 0.27 7.16 ± 0.23 7.92 ± 0.22
W/kg FFDM 28.9 ± 1.0 26.3 ± 1.2 28.6 ± 0.9
Diurnal energy expenditure
W 1.41 ± 0.05d 1.24 ± 0.04a 1.40 ± 0.03
W/kg LBM 6.10 ± 0.14b 5.86 ± 0.12 5.66 ± 0.11
W/kg FFDM 25.0 ± 0.6a,c 21.5 ± 0.6 20.8 ± 0.4
Nocturnal resting energy
expenditure
W 1.32 ± 0.05b,d 1.06 ± 0.05b 1.48 ± 0.04
W/kg LBM 5.73 ± 0.18d 5.02 ± 0.14b 5.99 ± 0.17
W/kg FFDM 22.9 ± 0.8d 18.4 ± 0.7b 21.6 ± 0.7
Daily resting energy
expenditure
W 1.16 ± 0.04d 0.97 ± 0.04b 1.15 ± 0.02
W/kg LBM 5.03 ± 0.13a,d 4.56 ± 0.11 4.65 ± 0.10
W/kg FFDM 20.6 ± 0.7a,c 16.8 ± 0.5 17.1 ± 0.3
LBM: lean body mass; FFDM: fat-free dry mass. aP < 0.05, bP < 0.01 vs AL;
cP < 0.05, dP < 0.01 vs PF. n = 6 per group. Means ± s.e.m.
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Figure 2 Mean body temperature (A), amplitude of the body temperature
rhythm (B), and hour of the acrophase (C) in tumour-bearing rats (   ),
pair-fed control rats (   ) and ad libitum-fed control rats (∆ ) determined by the
cosinor method on periods of four nycthemerons, each period of
determination beginning 2 days before the end of the preceding period
(for full details, see the Materials and Methods section). *P < 0.05 vs ad
libitum-fed control rats; ¶P < 0.05 vs pair-fed control rats. n = 8 per group.
Means ± s.e.m.Body temperature
Mean body temperature as determined by cosinor analysis (Figure
2) was 0.35° C higher in the TB group than in the two control
groups during the period from day 6 to day 10 after tumour
implantation (Figure 2A). The amplitude of the body temperature
rhythm was 0.25° C lower in the TB group than in the two control
groups (Figure 2B). The time of acrophase of body temperature
rhythm was delayed in the TB group compared to the PF and AL
groups. During the days 6–10 after tumour implantation, the delay
was about 2 h (Figure 2C).
The increase in daily mean body temperature started the 6th day
post-implantation. The daily mean body temperature was signifi-
cantly elevated in the TB group from the 7th day and was 0.35° C
higher in the TB group than in the two control groups during the
last 3 days of tumour growth (Figure 3). Moreover, the higher
body temperature in the TB group than in the two control groups
was limited to the light period of the nycthemeron (Figure 4).
DISCUSSION
The results of the studies concerning the involvement of elevated
energy expenditure in the aetiology of cancer cachexia are contra-
dictory. Studies report either an increase, a decrease, or no change
in the energy expenditure of cancerous humans and animals
(Keller, 1993; Ogilvie et al, 1993). Such conflicting results might
be explained by different tumour types (Fredrix et al, 1991).
Our study was undertaken to investigate the modification of
energy metabolism in rats bearing the Yoshida sarcoma. This
tumour has a rapid development and induces cachexia character-
ized by anorexia, a degradation of nitrogen balance, and an alter-
ation of the host body composition (Oudart et al, 1993). To our
knowledge, our study is the first to give detailed information on
the energetic changes related to the development of Yoshida
sarcoma. Importantly, it gives for the first time results on the
effects of tumour development on circadian aspects of energy
expenditure and body temperature.
The Yoshida sarcoma bearing rats were anorectic and it is well
known that anorexia is a common feature of tumour development.
We did not determine the body composition in this study.
However, the lower masses of retroperitoneal white fat pads and of
muscles in the TB rats than in the control animals indicate that
the Yoshida sarcoma induces a cachexia, as previously showed
(Oudart et al, 1993). Moreover, the masses of muscles, retroperi-
toneal white fat pads and brown adipose tissue were lower in the
TB group than in the PF group, implying that the cachexia induced
by the Yoshida sarcoma is not solely due to the reduction of the
food-intake. Such results are in accordance with a study on female
rats which showed that the masses of gastrocnemius muscle and
parametrial white fad pads are lower in Yoshida sarcoma bearing
animals than in pair-fed control animals (McCarthy et al, 1993).
Energy expenditure and body temperature: overall data
As demonstrated by the larger final than initial body masses, the
energy balance remained positive in the TB and PF groups.
However, the classical decrease in energy expenditure, which is
associated with a decrease in food intake (Forsum et al, 1981) was
observed in the PF group but not in the TB one. The total energy
expenditure, excepted when expressed in W per unit of lean body
mass, was higher in the TB rats than in the PF rats, indicating that
an increase in the total energy expenditure is involved in the aeti-
ology of the cachexia induced by the Yoshida sarcoma. The lack of
difference in energy expenditure expressed in W per unit of lean
body mass between the TB and PF rats was probably due to the
increase in water body content which is observed in tumour-
bearing rats (Oudart et al, 1993). So, to avoid the influence of the
variations in body water, the better standardization of energy
expenditure are in relation to the FFDM. In this way, the higher
total energy expenditure in TB rats than in the PF rats evidences
that the difference are not due to modifications of the body compo-
sition. Whatever the energy expenditure component (diurnal,
nocturnal, resting), the value of the PF group was lower than the
value of the AL group. These differences vanish when the
components of the energy expenditure are expressed by unit of
FFDM (excepted for the nocturnal resting energy expenditure),
evidencing that the differences in energy expenditure between the
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Figure 3 Daily mean body temperature in tumour-bearing rats (   ), pair-fed
control rats (   ), and ad libitum-fed control rats (∆ ) during the tumour
development. Day 0: day of the implantation of the tumour. *P < 0.05 vs ad
libitum-fed and pair-fed control rats; ¶P < 0.05 vs the day preceding the day
0. n = 8 per group. Means ± s.e.m.
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Figure 4 Hourly mean body temperature in tumour-bearing rats (   ),
pair-fed control rats (   ), and ad libitum-fed control rats (∆ ) during the last
nycthemeron of tumour development. *P < 0.05 vs ad libitum-fed and pair-fed
control rats. n = 8 per group. Means ± s.e.m.PF and AL groups were mainly due to the modification of body
composition.
Expressed in watts per animal, the differences in the resting
energy expenditure paralleled the differences observed in the total
energy expenditure. However, contrary to the total energy expen-
diture, the resting energy expenditure expressed per unit of FFDM
was higher in the TB group than in the two control groups, demon-
strating that the Yoshida sarcoma induces an increase in the resting
energy expenditure, despite the anorexia associated with the
tumour development. Two hypothesis, not mutually exclusive,
might explain the difference in resting energy expenditure,
whereas the total energy expenditure did not differ between the TB
group and the two control groups. First, the locomotor activity was
dramatically decreased in Yoshida sarcoma-bearing rats compared
to control animals (personal data). This lower physical activity in
the TB rats than in control animals could at least in part explain the
lack of difference in total energy expenditure, despite a higher
resting energy expenditure in TB rats. Second, the food intake was
lower in TB rats than in the AL rats. Thus it is highly probable that
the energy expenditure due to feeding (diet-induced thermo-
genesis, at least the obligatory component) is lower in TB rats than
in AL rats. This difference in diet-induced thermogenesis might
also explain the observed results. Such decrease in activity and
diet-induced energy expenditures leading to a lack of difference in
total energy expenditure whereas the resting energy expenditure is
elevated has been shown in rats bearing the Morris hepatoma
(Luketich et al, 1990).
Fever is often associated with cancer cachexia (McCarthy and
Daun, 1993; Tessitore et al, 1993), although cachexia induced by a
tumour such as the methylcholantrene sarcoma is associated with a
drop of body temperature (Smith et al, 1993). Rats bearing the
Yoshida hepatoma, which is a tumour close to the Yoshida
sarcoma, show an increase in body temperature during the first
days of tumour development followed by a drop of body tempera-
ture below normal values in later stages (day 10 after tumour
implantation) of tumour development (Tessitore et al, 1993). In
our model of cancer cachexia, the tumour-bearing rats presented
an increase in body temperature, which persisted until the last day
of tumour development.
Fever associated with cancer cachexia or induced by endotoxin
is due to the pyrogen effect of cytokines such as interleukin 1β and
interleukin 6 (Busbridge et al, 1993; Roth et al, 1993), whereas
tumour necrosis factor seems to attenuate the fever induced by the
interleukin 1β or endotoxin (Long et al, 1992). There are no avail-
able data concerning cytokines in Yoshida sarcoma-bearing rats
and we did not measure the circulating cytokines in the present
study. Yet, it is possible that the Yoshida sarcoma induces high
levels of circulating of cytokines in the host.
Energy expenditure and body temperature:
nycthemeral data
There are few reports of circadian rhythm of body temperature in
tumour-bearing rats. To our knowledge, the most complete study
was performed on rats bearing the methylcholantrene sarcoma,
which induces a drop in body temperature (Smith et al, 1993). This
drop is limited to the dark phase of the nycthemeron in the first
stages of tumour growth and extended over the complete nycthe-
meron with the tumour development. In the Walker 256 carcinoma
bearing rats, a fever is present throughout the nycthemeron
(McCarthy and Daun, 1993). In our model, the fever was limited to
the light phase of the nycthemeron throughout the tumour develop-
ment. Moreover, the rats bearing the Yoshida sarcoma presented a
delay in the acrophase of body temperature rhythm. To our knowl-
edge, it is the first time that a phase shift in the body temperature
rhythm is reported in tumour-bearing rats exposed to normal
photoperiod.
In accordance with these changes in body temperature, the
energy expenditure of tumour-bearing rats did not differ from
controls during the dark phase of the nycthemeron whereas during
the light phase, which is the period of lower physical activity in the
rat, the energy expenditure was higher in tumour-bearing rats than
in control rats.
This diurnal fever could be explained by the rhythm of
cytokines production. Indeed, in human patients with colorectal or
gastrointestinal cancers, a rhythm in circulating tumour necrosis
factor is detected with a peak in the middle of the night (about
02:00 h) and a lower value in the afternoon (about 12:00 h) (Muc-
Wierzgon et al, 1996, 1998). The effect of cytokines may also be
subjected to day–night modulation. Indeed, it has been shown in
mice that interferon α induces fever during the light phase but not
during the dark phase of the nycthemeron (Ohdo et al, 1997).
Our study therefore demonstrates that the Yoshida sarcoma
induces an increase in resting energy expenditure and a fever,
which are limited to the light phase of the nycthemeron. Moreover,
there is a phase shift in the circadian rhythm of body temperature.
Cytokines are probably implicated in this effect. Further experi-
ments should be performed to determine the role of the different
cytokines in the fever and in the increase in energy expenditure,
and particularly in the circadian aspects.
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